Title | Type | SJR | H index | Total Docs. (2002) | Total Docs. (3years) | Total Refs. (2002) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2002) | %Female (2002) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100 | American Journal of PharmacoGenomics | journal | 0.286 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
99 | Assay and Drug Development Technologies | journal | 65 | 12 | 0 | 87 | 0 | 0 | 0.00 | 7.25 | 40.00 | ||
98 | Cancer Biology and Therapy | journal | 130 | 136 | 0 | 4683 | 0 | 0 | 0.00 | 34.43 | 28.09 | ||
97 | Central Nervous System Agents in Medicinal Chemistry | journal | 39 | 18 | 0 | 1877 | 0 | 0 | 0.00 | 104.28 | 32.50 | ||
96 | Expert Review of Vaccines | journal | 105 | 57 | 0 | 3050 | 0 | 0 | 0.00 | 53.51 | 28.97 | ||
95 | Methods in molecular medicine | book series | 59 | 150 | 0 | 308 | 0 | 0 | 0.00 | 2.05 | 30.84 | ||
94 | Molecular Cancer | journal | 196 | 9 | 0 | 361 | 0 | 0 | 0.00 | 40.11 | 29.41 | ||
93 | Molecular Imaging | journal | 66 | 22 | 0 | 933 | 0 | 0 | 0.00 | 42.41 | 22.52 | ||
92 | NeuroMolecular Medicine | journal | 82 | 39 | 0 | 2922 | 0 | 0 | 0.00 | 74.92 | 28.23 | ||
91 | Pharmaceutica Acta Helvetiae | journal | 0.840 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
90 | BMC Chemical Biology | journal | 0.293 Q4 | 21 | 1 | 4 | 30 | 4 | 4 | 1.00 | 30.00 | 60.00 | |
89 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.116 Q4 | 45 | 11 | 8 | 951 | 2 | 8 | 0.25 | 86.45 | 19.05 | |
88 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.502 Q3 | 108 | 39 | 18 | 5020 | 22 | 18 | 1.22 | 128.72 | 28.16 | |
87 | Mitochondrion | journal | 0.722 Q3 | 109 | 37 | 18 | 1849 | 27 | 18 | 1.50 | 49.97 | 37.59 | |
86 | Progress in Medicinal Chemistry | journal | 1.175 Q2 | 38 | 11 | 21 | 1722 | 70 | 13 | 2.93 | 156.55 | 13.64 | |
85 | Current Gene Therapy | journal | 0.350 Q3 | 80 | 34 | 24 | 4126 | 26 | 24 | 1.08 | 121.35 | 27.66 | |
84 | Infectious Disorders - Drug Targets | journal | 0.284 Q4 | 61 | 30 | 27 | 2772 | 21 | 27 | 0.78 | 92.40 | 28.91 | |
83 | Molecular Aspects of Medicine | journal | 1.972 Q1 | 159 | 13 | 29 | 2590 | 161 | 27 | 5.88 | 199.23 | 25.00 | |
82 | Molecular Interventions | journal | 0.698 Q3 | 78 | 58 | 30 | 1927 | 29 | 30 | 0.97 | 33.22 | 19.30 | |
81 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.118 Q4 | 29 | 8 | 31 | 377 | 4 | 12 | 0.10 | 47.13 | 10.53 | |
80 | OMICS A Journal of Integrative Biology | journal | 0.723 Q3 | 69 | 33 | 35 | 885 | 52 | 31 | 1.59 | 26.82 | 22.08 | |
79 | Mini-Reviews in Medicinal Chemistry | journal | 0.328 | 107 | 51 | 38 | 4269 | 40 | 38 | 1.05 | 83.71 | 25.44 | |
78 | Drugs Made in Germany | journal | 0.100 Q4 | 4 | 13 | 40 | 169 | 0 | 37 | 0.00 | 13.00 | 28.13 | |
77 | Progress in Drug Research | book series | 0.618 Q3 | 46 | 14 | 45 | 1733 | 99 | 40 | 2.00 | 123.79 | 9.52 | |
76 | Current Drug Targets | journal | 1.182 Q2 | 119 | 40 | 50 | 4034 | 145 | 46 | 2.90 | 100.85 | 22.22 | |
75 | Expert Reviews in Molecular Medicine | journal | 0.317 Q4 | 93 | 28 | 51 | 2859 | 26 | 51 | 0.50 | 102.11 | 39.44 | |
74 | Current Molecular Medicine | journal | 0.592 Q3 | 117 | 62 | 54 | 7244 | 81 | 54 | 1.50 | 116.84 | 34.06 | |
73 | Drug Design and Discovery | journal | 0.344 Q4 | 20 | 4 | 55 | 48 | 49 | 50 | 0.88 | 12.00 | 16.67 | |
72 | Pharmacogenomics Journal | journal | 0.547 Q3 | 95 | 63 | 56 | 2185 | 103 | 50 | 1.84 | 34.68 | 28.50 | |
71 | Pteridines | journal | 0.205 Q4 | 19 | 18 | 62 | 526 | 33 | 62 | 0.40 | 29.22 | 20.63 | |
70 | Journal of Cellular and Molecular Medicine | journal | 0.146 Q4 | 157 | 57 | 64 | 2950 | 30 | 64 | 0.47 | 51.75 | 45.63 | |
69 | Pharmacological Reviews | journal | 12.251 Q1 | 254 | 23 | 64 | 6417 | 1857 | 63 | 27.44 | 279.00 | 7.79 | |
68 | Journal of Molecular Diagnostics | journal | 1.234 Q2 | 111 | 33 | 66 | 1191 | 252 | 62 | 4.07 | 36.09 | 33.10 | |
67 | Advances in Biological Regulation | journal | 1.401 Q1 | 69 | 34 | 67 | 1068 | 189 | 65 | 2.64 | 31.41 | 27.88 | |
66 | Expert Review of Molecular Diagnostics | journal | 0.314 Q4 | 89 | 100 | 69 | 3648 | 77 | 65 | 1.12 | 36.48 | 28.35 | |
65 | Pharmacogenomics | journal | 1.058 Q2 | 100 | 84 | 75 | 4272 | 291 | 70 | 3.88 | 50.86 | 23.94 | |
64 | SAR and QSAR in Environmental Research | journal | 0.337 Q4 | 54 | 61 | 79 | 0 | 96 | 79 | 1.05 | 0.00 | 27.16 | |
63 | Medicinal Research Reviews | journal | 1.869 Q1 | 150 | 26 | 84 | 3534 | 481 | 83 | 6.92 | 135.92 | 39.68 | |
62 | Molecular Informatics | journal | 0.356 Q3 | 75 | 33 | 87 | 1445 | 120 | 87 | 1.41 | 43.79 | 19.32 | |
61 | Progress in Molecular Biology and Translational Science | journal | 4.152 Q1 | 113 | 23 | 95 | 4314 | 565 | 93 | 5.40 | 187.57 | 29.51 | |
60 | Journal of Asian Natural Products Research | journal | 0.272 Q4 | 51 | 49 | 112 | 529 | 43 | 112 | 0.43 | 10.80 | 32.94 | |
59 | Drugs under Experimental and Clinical Research | journal | 0.447 Q3 | 41 | 33 | 116 | 862 | 172 | 114 | 0.55 | 26.12 | 33.33 | |
58 | Viral Immunology | journal | 0.594 Q3 | 70 | 59 | 123 | 3136 | 191 | 117 | 1.64 | 53.15 | 35.95 | |
57 | Journal of Trace Elements in Medicine and Biology | journal | 0.377 Q3 | 92 | 38 | 124 | 1271 | 110 | 124 | 0.70 | 33.45 | 38.64 | |
56 | Journal of Biochemical and Molecular Toxicology | journal | 0.612 Q3 | 69 | 40 | 129 | 1613 | 238 | 128 | 1.80 | 40.33 | 35.51 | |
55 | ChemBioChem | journal | 1.528 Q1 | 142 | 160 | 131 | 6943 | 443 | 129 | 3.38 | 43.39 | 25.69 | |
54 | Expert Opinion on Therapeutic Targets | journal | 0.474 Q3 | 106 | 54 | 131 | 5107 | 108 | 131 | 1.04 | 94.57 | 24.79 | |
53 | Extremophiles | journal | 1.060 Q2 | 95 | 64 | 133 | 2190 | 302 | 133 | 2.45 | 34.22 | 26.94 | |
52 | Experimental and Molecular Medicine | journal | 0.760 Q2 | 115 | 69 | 135 | 2145 | 210 | 135 | 1.18 | 31.09 | 32.47 | |
51 | Journal of Biomolecular Screening | journal | 0.771 Q2 | 86 | 56 | 137 | 1170 | 301 | 120 | 1.87 | 20.89 | 27.82 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®